Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
GLOBETECH PUBLISHING LLC
FOCUS DIAGNOSTICS, INC.

High Levels of Vascular Endothelial Growth Factor Mark Noncancerous Pancreatic Cysts

By Labmedica International staff writers
Posted on 27 Feb 2014
Image: A benign pancreatic cyst is evident at the tip of the clamp in this photo (Photo courtesy of the Indiana University School of Medicine).
Image: A benign pancreatic cyst is evident at the tip of the clamp in this photo (Photo courtesy of the Indiana University School of Medicine).
A new noninvasive diagnostic test can differentiate benign pancreatic cysts from those that have the potential to progress to invasive pancreatic adenocarcinoma (pancreatic cancer).

Serous cystic neoplasms (SCN) have no malignant potential, but can mimic mucinous pancreatic cysts, which have the potential to progress to invasive pancreatic adenocarcinoma, on imaging. The inability of medical imaging to readily differentiate between these two classes of cysts can result in patients having to go through extensive follow-up medical visits, invasive biopsies, and unnecessary surgery to determine the true nature of their pancreatic cyst.

Investigators at the Indiana University School of Medicine (Indianapolis, USA) hypothesized that vascular endothelial growth factor (VEGF)-A levels in pancreatic fluid might correlate with pathologic diagnosis of the pancreatic cyst. They used an ELISA assay to determine VEGF-A levels in pancreatic cyst fluid taken from 87 patients with suspicious pancreatic growths including pseudocysts, SCN, mucinous cystic neoplasm, low/moderate grade intraductal papillary mucinous neoplasm, high-grade/invasive intraductal papillary mucinous neoplasm, and pancreatic ductal adenocarcinoma.

Analysis of the data revealed that VEGF-A was significantly upregulated in SCN cyst fluid compared with all other diagnoses, and that VEGF-A had 100% sensitivity and 97% specificity as an SCN biomarker.

Senior author Dr. C. Max Schmidt, professor of surgery, biochemistry, and molecular biology at the Indiana University School of Medicine, said, "This is the first cyst fluid protein biomarker that can differentiate serous cystic neoplasms, a benign type of cystic lesion, from all other cancerous or precancerous cystic lesions without surgery."

"Only 15% of pancreatic cancer patients will benefit from surgery, and of those, only about 20% will survive five years," said Dr. Schmidt. "Many of my patients when initially told they have pancreatic cysts are very fearful and ask for surgical removal of the cyst or the entire pancreas before they even learn their options. Now, physicians will have an outpatient procedure to offer that can take some of the guesswork out of the equation.”

The study was published in December 24, 2013, online edition of the Journal of the American College of Surgeons.

Related Links:

Indiana University School of Medicine



MEDLAB Asia
CELLAVISION AB
KARL HECHT GMBH & CO KG
PERIPHERAL VISIONS INC

Channels

Clinical Chemistry

view channel
Image: UniCel DxC 800 Synchron Clinical Systems (Photo courtesy of Beckman Coulter).

Routine Blood Glucose Value Correlates with Diabetes Risk

Random glucose values obtained during routine blood tests are often overlooked, but could provide valuable insight into whether someone is at risk for having type 2 diabetes. Random Blood Glucose (RBG)... Read more

Genetic Tests

view channel
Image: Histopathology of tuberculoid leprosy in a skin section (Photo courtesy Dr. D.S. Ridley, Wellcome Images).

Genes Discovered Influence Risk of Developing Leprosy

Leprosy, a chronic dermatological and neurological disease, is caused by infection with Mycobacterium leprae, and its manifestation, progression and prognosis are strongly associated with the proficiency... Read more

Hematology

view channel
Image: Plastic bag containing 0.5 to 0.7 liters of packed red blood cells in citrate, phosphate, dextrose, and adenine (CPDA) solution (Photo courtesy of Fresenius HemoCare).

Transfusion Protocols Compared After Cardiac Surgery

Unnecessary blood transfusions may increase healthcare costs both directly, because blood is an increasingly scarce and expensive resource, and indirectly due to the complications associated with transfusion.... Read more

Industry News

view channel

Sequencing-Based Testing Sector Already Highly Competitive

As next-generation sequencing (NGS) reaches the clinical laboratory, a new analysis by Kalorama Information (New York, NY, USA) finds that small reference laboratories as well as over 50 companies now offer sequencing-based testing through their own CLIA-certified laboratories, some of which offer a wide range of tests.... Read more
 

Events

28 Mar 2015 - 01 Apr 2015
06 Apr 2015 - 08 Apr 2015
07 Apr 2015 - 09 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.